About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Evil Thoughts of Evil Things | Main | Merck: Unfigure-outable »

August 30, 2006

Those Darn Invisible Creatures

Email This Entry

Posted by Derek

If you want to make your friends in the cell culture lab jump, just walk up behind them and shout "mycoplasma!" (What's that? You say you have no friends in the cell culture lab? Hmm. . .)

Mycoplasma is a scary word because they're scary little organisms. They're bacteria, just barely, running much smaller than usual and without any sort of cell wall. They also have the tiniest genomes you're likely to ever see - being parasitic allows them to get away with a pretty limited instruction set. They can cause diseases in humans and other animals (excellent review here), but they just love to hang out with your cultured cell lines, too.

From their (admittedly rather limited) perspective, what's not to like? Constant temperature, lots of food, and plenty of well-taken-care-of cells to mooch off of. Problem is, once they get in there, they alter the behavior of the cells they've infected, and you can't trust the results of your assays with them any more. Every cell culture lab tests for these things, and every one of them still has the occasional outbreak. It's the price of doing business. If the cells aren't precious, they're tossed - if they are, there are some antibiotics that will generally kill the little creatures off, but you still have to watch things closely for a while. (If you don't want to test them yourself, you can send samples to these guys, and they'll do it for you).

There have been periodic mycoplasma spasms in many research areas, as various groups have found that their results are suspect due to contamination. Since the little beasts pass right through filters that will strain out normal bacteria, and can't even be reliably seen under normal microscopy conditions in many cell cultures, a little paranoia is justified. Have you checked your cells recently?

Comments (4) + TrackBacks (0) | Category: Drug Assays


1. biohombre on August 30, 2006 11:00 PM writes...

"Outbreaks" of mycoplasma are generally due to inadequate material control. Careful screening of materials used for cell culture, as well as isolation of incoming cell lines (until verified to be clean) can provide for a lab with no outbreaks. Of course, good technique in handling of cultures is important, (can you go years without any antibiotics and maintain bacteria-free cultures?). I have worked in labs where we have successfully handled large numbers of different cell lines (40 or more) with no mycoplasma problems (on two different continents, no less). Academic labs that share cell lines and use budget sera etc. are prime sources for mycoplasma infections...

Permalink to Comment

2. Black Knight on August 30, 2006 11:52 PM writes...

Funny you should mention this, as I whiffled about this very matter a short while ago.

My cells are clean, by the way, and in the face of lack of interest from anyone else we've not done much more. But we could. . .

Permalink to Comment

3. Atompusher on August 31, 2006 5:03 PM writes...

Yeah, I love it when people walk up behind me and say bad things. One of the chemists I work with tends to walk up behind people and blurt out random words. I was looking at analytical results of impure fractions from a horrendus prep run when I heard: SHOW-DUR! Yes, I can see the shoulder on the peak, thanks. When people are purifying compounds we constantly hear HP-er-C.

Permalink to Comment

4. Morten on September 1, 2006 1:33 AM writes...

You forgot to mention that it generally takes months to cure cells of mycoplasma.
Happened to a friend of mine. She got cells from some other lab and found out that they were infected. And it tooks ages to finally get them clean and then she found out that were already oncogenic... Big waste of her time. Moral of the story is: if you are gonna cure cells of mycoplasma then triple check that they actually are the cells you want. And never trust anyone.

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry